{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:42:55Z","timestamp":1773038575023,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Malignant struma ovarii (MSO) is an extremely rare ovarian malignant tumor and there is limited data on the survival outcomes and prognostic predictors of MSO. The objectives of this study were to investigate the disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS) rates of patients with MSO, and also evaluate the prognostic factors in this population.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A retrospective study was conducted and 194 cases of MSO were selected. DFS was assessed by the logistic regression, OS by the Kaplan\u2013Meier method, and DSS was evaluated by the Cox regression.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The median age of these patients was 46.0 years; 142 cases (73.2%) were confined to the ovary and 52 cases (26.8%) had extraovarian metastasis at the initial diagnosis of MSO. During the follow-up, 75.3% of these patients showed no evidence of disease and 18.0% were alive with disease. Only 13 deaths occurred, with 10 attributed to MSO. The 5, 10, and 15-year OS rates were 91.4, 87.7, and 83.5%, respectively. The 5, 10, and 15-year DSS rates were 93.8, 90.0, and 85.7%, respectively. Logistic regression revealed that International Federation of Gynecology and Obstetrics (FIGO) stage IV was the only risk factor for DFS [<jats:italic>p<\/jats:italic> &amp;lt; 0.001; odds ratio (OR) 7.328; 95% CI 3.103\u201316.885, FIGO stage IV vs. stage I; <jats:italic>p<\/jats:italic> = 0.021; OR 4.750, 95% CI 1.264\u201317.856, FIGO stage IV vs. stage II-III]. The multivariate Cox regression analysis showed that poor differentiation was the only risk factor for both OS (<jats:italic>p<\/jats:italic> = 0.005, OR 6.406; 95% CI 1.730\u201323.717) and DSS (<jats:italic>p<\/jats:italic> = 0.001, OR 9.664; 95% CI 2.409\u201338.760), while age \u226545 years was the prognostic predictor for OS (<jats:italic>p<\/jats:italic> = 0.038, OR 4.959; 95% CI 1.093\u201322.508).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Survival outcomes were excellent in patients with MSO, irrespective of the treatment strategy, FIGO stage IV, age \u226545 years, and poor differentiation of tumors were the independent risk factors.<\/jats:p>","DOI":"10.3389\/fmed.2021.774691","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:54:55Z","timestamp":1640271295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii"],"prefix":"10.3389","volume":"8","author":[{"given":"Sijian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00004347-199310000-00008","article-title":"Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54cases","volume":"12","author":"Devaney","year":"1993","journal-title":"Int J Gynecol Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1089\/thy.2010.0022","article-title":"Lethal, malignant, metastatic struma ovarii","volume":"20","author":"Marcy","year":"2010","journal-title":"Thyroid."},{"key":"B3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ncpendmet0887","article-title":"Malignant struma ovarii","volume":"4","author":"Yassa","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13048-018-0383-2","article-title":"Precise preoperative diagnosis of struma ovarii with pseudo-Meigs' syndrome mimicking ovarian cancer with the combination of 131I scintigraphy and 18F\u2013FDG PET: case report and review of the literature","volume":"11","author":"Fujiwara","year":"2018","journal-title":"J Ovarian Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/09513590.2014.995616","article-title":"The lack of consensus in management of malignant struma ovarii","volume":"31","author":"Gonzalez Aguilera","year":"2015","journal-title":"Gynecol Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/bcr788","article-title":"Pathology and genetics: tumors of the breast and female genital organs","volume":"6","author":"Hanby","year":"2004","journal-title":"Breast Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1089\/105072501316973163","article-title":"Malignant struma ovarii: an unusual presentation","volume":"11","author":"Checrallah","year":"2001","journal-title":"Thyroid."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00404-019-05329-z","article-title":"Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature","volume":"300","author":"Siegel","year":"2019","journal-title":"Arch Gynecol Obstet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/thy.2014.0328","article-title":"Malignant struma ovarii: a population-level analysis of a large series of 68 patients","volume":"25","author":"Goffredo","year":"2015","journal-title":"Thyroid."},{"key":"B10","doi-asserted-by":"publisher","first-page":"584917","DOI":"10.3389\/fonc.2020.584917","article-title":"FIGO Stage IV and age over 55 years as prognostic predicators in patients with metastatic malignant struma ovarii","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12885-021-08118-7","article-title":"Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14902","article-title":"Malignant struma ovarii: from case to analysis","author":"Ayhan","year":"2021","journal-title":"J Obstet Gynaecol Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1200\/JCO.2016.68.9372","article-title":"Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems","volume":"34","author":"Adam","year":"2016","journal-title":"J Clin Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/cncr.29524","article-title":"Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"121","author":"Prat","year":"2015","journal-title":"Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1200\/JCO.2012.42.4457","article-title":"Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer","volume":"31","author":"Yang","year":"2013","journal-title":"J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/cncr.20087","article-title":"Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients","volume":"100","author":"Volante","year":"2004","journal-title":"Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/jc.2013-3842","article-title":"Outcomes in patients with poorly differentiated thyroid carcinoma","volume":"99","author":"Ibrahimpasic","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijsu.2012.10.005","article-title":"Changing trends in well differentiated thyroid carcinoma over eight decades","volume":"10","author":"Nixon","year":"2012","journal-title":"Int J Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/cncr.21739","article-title":"Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients","volume":"106","author":"Hiltzik","year":"2006","journal-title":"Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s00268-007-9033-3","article-title":"An evidence-based review of poorly differentiated thyroid cancer","volume":"31","author":"Sanders","year":"2007","journal-title":"World J Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00000478-199902000-00010","article-title":"Clinicopathological significance of poorly differentiated thyroid carcinoma","volume":"23","author":"Nishida","year":"1999","journal-title":"Am J Surg Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/thy.2018.0509","article-title":"Poorly differentiated carcinoma of the thyroid gland: current status and future prospects","volume":"29","author":"Ibrahimpasic","year":"2019","journal-title":"Thyroid."},{"key":"B25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/thy.2019.0688","article-title":"Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves theperformance of the american thyroid association stratification system","volume":"30","author":"Trimboli","year":"2020","journal-title":"Thyroid."},{"key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.oraloncology.2018.11.003","article-title":"A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma","volume":"87","author":"Nam","year":"2018","journal-title":"Oral Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1210\/jc.2017-02255","article-title":"Effect of age on response to therapy and mortality in patients with thyroid cancer at high risk of recurrence","volume":"103","author":"Shah","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B28","first-page":"232","article-title":"Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue","volume":"45","author":"Faggiano","year":"2004","journal-title":"J Nucl Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet Gynecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PGP.0b013e3181a27777","article-title":"Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread","volume":"28","author":"Robboy","year":"2009","journal-title":"Int J Gynecol Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/PGP.0b013e3181bfb133","article-title":"Natural history of biologically malignant428 struma ovarii: analysis of 27 cases with extraovarian spread","volume":"29","author":"Shaco-Levy","year":"2010","journal-title":"Int J Gynecol Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5858\/arpa.2011-0092-OA","article-title":"Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior","volume":"136","author":"Shaco-Levy","year":"2012","journal-title":"Arch Pathol Lab Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0090-8258(03)00141-0","article-title":"Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy","volume":"89","author":"DeSimone","year":"2003","journal-title":"Gynecol Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/thy.2011.0162","article-title":"Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases","volume":"22","author":"Marti","year":"2012","journal-title":"Thyroid."},{"key":"B36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4158\/EP.15.2.167","article-title":"Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation","volume":"15","author":"McGill","year":"2009","journal-title":"Endocr Pract."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.774691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:55:01Z","timestamp":1640271301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.774691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":36,"alternative-id":["10.3389\/fmed.2021.774691"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.774691","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"774691"}}